Clinical Trials Directory

Trials / Completed

CompletedNCT05825638

Evolution of Pulsed Oxygen Saturation During Interval Training Compared to Continuous Training in COPD Patients

Evolution of Pulsed Oxygen Saturation Throughout an Interval Training Session Compared to a Continuous Training Session in Patients With Chronic Obstructive Pulmonary Disease With Exercise-induced Oxygen Desaturation.

Status
Completed
Phase
Study type
Observational
Enrollment
12 (actual)
Sponsor
Groupe Hospitalier du Havre · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A problem often observed during exercise training is oxygen desaturation exclusively during exercise in some patients. In the case of exercise-induced desaturation, it may be suggested to train these patients in interval training to limit exercise-induced desaturation. Interval training consists of alternating active phases of short duration (often 30 seconds to 1 minute) followed by a short active or passive recovery phase of equivalent duration to the previous phase. Investigators therefore hypothesise that interval training on a cycloergometer or treadmill can limit exercise-induced desaturation in COPD patients. The aim of the study is to observe the evolution of pulsed oxygen saturation between a continuous training session and a interval training session.

Conditions

Interventions

TypeNameDescription
OTHERContinuous training sessionContinuous training consists of a 5 minute warm up, 5 minute cool down and 20 minutes of moderate intensity work. The workload is set at 60% of the patient's maximum power
OTHERInterval training sessionInterval training consists of a 5-minute warm-up, a 5-minute cool-down and 20 minutes of alternating 60 seconds of high-intensity work (100% of the maximum power recorded in the incremental test that was carried out when the patient was admitted to the pulmonary rehabilitation department) and 60 seconds of unloaded pedalling or rest.

Timeline

Start date
2023-01-10
Primary completion
2025-09-30
Completion
2025-10-10
First posted
2023-04-24
Last updated
2026-01-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05825638. Inclusion in this directory is not an endorsement.